06 Nov, 16:14 - Indian

SENSEX 80378.13 (1.13)

Nifty 50 24484.05 (1.12)

Nifty Bank 52317.4 (0.21)

Nifty IT 42039.5 (3.99)

Nifty Midcap 100 57355.8 (2.21)

Nifty Next 50 71389.8 (2.28)

Nifty Pharma 22920.35 (1.14)

Nifty Smallcap 100 18906.1 (2.18)

06 Nov, 16:14 - Global

NIKKEI 225 39480.67 (2.61)

HANG SENG 20538.38 (-2.23)

S&P 5947.5 (2.12)

Login/Signup
LOGIN HERE
Cancel

Vijaya Diagnostic Centre Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 543350 | NSE Symbol : VIJAYA | ISIN : INE043W01024 | Industry : Healthcare |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
27-Jul-2024 05-Aug-2024 Quarterly Results Vijaya Diagnostic Centre Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2024 inter alia to consider and approve the standalone and consolidated unaudited financial results of the Company for the first quarter ended June 30 2024; and Other corporate matters. Please find enclosed herewith the Outcome of Board meeting held on Aug 05, 2024 (As per BSE Announcement Dated on 05/08/2024)
29-Apr-2024 08-May-2024 Final Dividend Final Dividend & Audited Results Vijaya Diagnostic Centre Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/05/2024 ,inter alia, to consider and approve 1. The standalone and consolidated audited financial results of the Company for the quarter and year ended March 31, 2024; 2. Recommend the dividend, if any, for the financial year ended March 31, 2024; and 3. Other corporate matters Outcome of Board meeting held on May 08, 2024. as per attachment Recommendation of Final Dividend of ?1/- per equity share i.e., 100% of the face value, for the financial year ended March 31, 2024 Re-appointment of Whole-time Directors. Re-appointment of Cost Auditor for FY2024-25 Grant of 2,41,470 ESOPs under the Employee Stock Option Plan 2018 (As Per BSE Announcement Dated on 08/05/2024)
23-Jan-2024 05-Feb-2024 Quarterly Results Vijaya Diagnostic Centre Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2024 inter alia to consider and approve 1. The Unaudited standalone and consolidated financial results of the Company for the third quarter and nine months ended December 31 2023; and 2. Other corporate matters. As per attachment (As Per BSE Announcement Dated on 05/02/2024)
19-Dec-2023 19-Dec-2023 Acquisitions We hereby inform you that the Board of Directors of Vijaya Diagnostic Centre Limited ('the Company'), at their meeting held today, (i.e. December 19, 2023), have inter-alia considered and approved the terms and conditions of the Share Purchase agreement ('SPA') between the Company, P H Diagnostic Centre Private Limited ('P H / Target') and its Promoters/Shareholders ('Sellers') for the acquisition of 100% stake in 'P H'. Post completion of the aforesaid acquisition, 'P H' will become wholly-owned subsidiary ('WOS') of the Company. Details required to be disclosed under the SEBI Listing Regulations, 2015 read with Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated 13th July 2023 have been provided in Annexure - I to this letter. The Meeting commenced at 12:15 P.M. IST and concluded at 12:45 P.M. IST Please take the above information on record.
19-Oct-2023 07-Nov-2023 Quarterly Results Vijaya Diagnostic Centre Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2023 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended 30 September 2023 As per attachment As per attachment (As Per BSE Announcement Dated on 07.11.2023)
31-Jul-2023 09-Aug-2023 Quarterly Results Vijaya Diagnostic Centre Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2023 inter alia to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the first quarter ended June 30 2023 As per attachment. As per attachment (As Per BSE Announcement Dated on 09.08.2023)
11-May-2023 29-May-2023 Accounts Vijaya Diagnostic Centre Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 inter alia to consider and approve 1. The standalone and consolidated audited financial results of the Company for the quarter and year ended March 31 2023; 2. Recommend the dividend if any for the financial year ended March 31 2023; and 3. Other corporate matters. As per attachment We hereby inform you that, the Board of Directors in their meeting held today i.e., on Monday, May 29, 2023, has inter-alia considered and approved the re-appointment of M/s. B S R and Co., Chartered Accountants (Firm Registration No. 128510W) as the Statutory Auditors of the Company for a period of five (5) consecutive years commencing from the conclusion of 21st Annual General Meeting till the conclusion of the 26th Annual General Meeting of the Company, subject to the approval of the shareholders at the ensuing 21st Annual General Meeting of the Company. We hereby inform you that, the Board of Directors in their meeting held today i.e., on Monday, May 29, 2023, has inter-alia considered and approved the re-appointment of M/s. Santhosh & Associates, Cost Accountants (Firm Registration No. 003955) as the Cost Auditors of the Company for the Financial Year 2023-24. (As Per BSE Announcement Dated on 29.05.2023)
02-Feb-2023 13-Feb-2023 Quarterly Results Vijaya Diagnostic Centre Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 inter alia to consider and approve 1. The Unaudited Financial Results (both Standalone and Consolidated) for the third quarter and nine months ended 31st December 2022; and 2. Other Corporate Matters. As per attachment (As Per BSE Announcement Dated on 13/02/2023)
21-Oct-2022 10-Nov-2022 Quarterly Results Vijaya Diagnostic Centre Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2022 inter alia to consider and approve Pursuant to Regulation 29 and other applicable provisions of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 if any we hereby inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Thursday November 10 2022 inter-alia to consider and approve the Un-audited standalone and consolidated financial results of the Company for the second quarter and half year ended September 30 2022. Kindly take the information on record. We are enclosing herewith the Un-audited standalone and consolidated financial results of the Company for the second quarter and half year ended September 30, 2022.together with limited review report(s) of Statutory Auditor The Board of Directors of the Company at their meeting held on November 10, 2022 has, inter-alia considered and approved the following items; 1. Un-audited standalone and consolidated financial results of the Company for the second quarter and half year ended September 30, 2022. 2. Shifting of Registered Office of the Company from '3-6-16 & 17, Street No.19 Himayatnagar Hyderabad Telangana 500029' to '6-3-883/F,FPA Building, Near Topaz building, Punjagutta, Hyderabad Telangana 500082', which is within the local limits of the city/town. Further the Board of Directors of the Company had taken note of the resignation submitted by Ms. Anusha Kanumuru, Company Secretary & Compliance Officer and she will be relieved from the services on or before December 31, 2022. The meeting of the Board commenced at 12:10 p.m. and concluded at 1:35 p.m. We hereby inform you that the Board of Directors of the Company at their meeting held today i.e. Thursday, November 10, 2022 has, inter-alia considered and approved Shifting of Registered Office of the Company from '3-6-16 & 17, Street No.19 Himayatnagar Hyderabad Telangana 500029' to '6-3-883/F,FPA Building, Near Topaz building, Punjagutta, Hyderabad Telangana 500082', which is within the local limits of the city/town. (As per BSE Announcement Dated on 10/11/2022)
01-Aug-2022 09-Aug-2022 Quarterly Results Quarterly Results Vijaya Diagnostic Centre Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2022 ,inter alia, to consider and approve Pursuant to Regulation 29 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 if any, we hereby inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, August 09, 2022, inter-alia to consider and approve the Un-audited standalone and consolidated financial results of the Company for the first quarter ended June 30, 2022. (As Per BSE Announcement Dated on 30/07/2022) We hereby inform you that the Board of Directors of the Company at their meeting held today i.e. Tuesday, August 09, 2022 has, inter-alia considered and approved the Un-audited standalone and consolidated financial results of the Company for the first quarter ended June 30, 2022. The copy of the aforesaid un-audited financial results of the Company together with limited review report(s) of Statutory Auditor are annexed herewith. We hereby inform you that the Board of Directors of the Company at their meeting held today i.e. Tuesday, August 09, 2022 has, inter-alia considered and approved the Un-audited standalone and consolidated financial results of the Company for the first quarter ended June 30, 2022. The copy of the aforesaid un-audited financial results of the Company together with limited review report(s) of Statutory Auditor are annexed herewith. (As Per BSE Announcement Dated on 09.08.2022)
17-May-2022 26-May-2022 Accounts Final Dividend & Audited Results We hereby inform you that the Board of Directors of the Company at their meeting held today has, inter-alia approved the following items of business. 1. Audited Standalone and Consolidated financial statements of the Company for the financial year ended March 31, 2022. 2. Recommended final dividend of 100% i.e. Re 1/- per equity share of face value of Re. 1/- each, for the Financial year ended March 31, 2022 and the said Dividend, if approved and declared by the shareholders at the forthcoming Annual General Meeting (AGM), will be paid within 30 days from the date of the AGM. The date of AGM and record date for the purpose of AGM and Dividend will be intimated in due course. (As Per BSE Announcement Dated on 26/05/2022) Pursuant to the provisions of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we have published the audited financial results of the Company for the Financial year ended March 31, 2022 in Financial Express (English) and Nava Telangana (Telugu) newspapers on May 28, 2022. Copies of the said Newspaper publications are enclosed herewith. (As per BSE Announcement Dated on 28.05.2022)
27-Jan-2022 04-Feb-2022 Quarterly Results Quarterly Results Vijaya Diagnostic Centre Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2022 ,inter alia, to consider and approve Unaudited standalone and consolidated financial results of the Company for the quarter ended December 31, 2021 The Board of Directors of the Company at its meeting held on February 4, 2022, has inter alia, considered and approved the Un-audited standalone and consolidated Financial Results of the Company for the third quarter ended December 31, 2021 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. We enclose herewith the said Un-audited standalone and consolidated Financial Results along with the Limited Review Report(s) of the Statutory Auditor of the Company. The Board meeting commenced at 3.55 p.m. and concluded at 5.05 p.m. The Board of Directors of the Company at its meeting held on February 4, 2022 has inter alia considered and approved the following:- 1. Unaudited standalone and consolidated financial results of the Company for the quarter ended December 31, 2021. The copy of the aforesaid un-audited financial results of the Company together with Limited Review Report(s) of Statutory Auditor is enclosed herewith as Annexure I. 2. Authorized the Key Managerial Personnel (KMP) of the Company to determine the materiality of events as prescribed under Regulation 30 (5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; Details of the KMP are enclosed as Annexure II. The Board meeting commenced at 3.55 p.m. and concluded at 5.05 p.m. (As Per BSE Announcement Dated on 04.02.2022)
25-Oct-2021 08-Nov-2021 Quarterly Results Quarterly Results
1